Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 3,195 shares at $11.22 ($36K) on 2020-05-18, disclosed to the SEC on 2020-05-20.
Scheduled sale ($36k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |